Item Details

Print View

Drug Industry Antitrust Act [electronic resource]: Hearings Before the United States House Committee on the Judiciary, Subcommittee on Antitrust, Eighty-Seventh Congress, Second Session, on May 17, 18, 23, 24, 1962

United States. Congress. House. Committee on the Judiciary. Subcommittee No. 5
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O., 1962.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.J 89/1:87/32
Summary
Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.
Considers (87) S. 1552, (87) H.R. 6245.
Description
vii, 908 p. ; cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1962-HJH-0010
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 02767nam a22003491a 4500
    001 cis2007427365
    006 m d f
    007 cr bn mmmapmmp
    008 090623s1962 dcu s f000 0 eng d
    086
    0
      
    a| Y 4.J 89/1:87/32
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on the Judiciary. b| Subcommittee No. 5.
    245
    1
    0
    a| Drug Industry Antitrust Act h| [electronic resource] : b| hearings before the United States House Committee on the Judiciary, Subcommittee on Antitrust, Eighty-Seventh Congress, second session, on May 17, 18, 23, 24, 1962.
    260
      
      
    a| Washington : b| U.S. G.P.O., c| 1962.
    300
      
      
    a| vii, 908 p. ; c| cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1962-HJH-0010
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    520
      
      
    a| Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.
    520
      
      
    a| Considers (87) S. 1552, (87) H.R. 6245.
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    610
    1
    0
    a| United States. b| Food and Drug Administration.
    650
      
    0
    a| Pharmaceutical policy z| United States.
    650
      
    0
    a| Drugs x| Law and legislation z| United States.
    650
      
    0
    a| Pharmaceutical industry z| United States x| Standards.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on the Judiciary. Subcommittee No. 5. t| Drug Industry Antitrust Act
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on the Judiciary. Subcommittee No. 5. t| Drug Industry Antitrust Act. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS Hrgs MF Gp 3--(87) H1952-1 w| (ProQuest)cis10701408
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1962-HJH-0010 y| Electronic resource (PDF)
    998
      
      
    a| cis10701408
    040
      
      
    a| UMI c| UMI
▾See more
▴See less

Availability

Read Online